# Anavex Life Sciences Corp. (AVXL) SEC filings and CIK

Canonical: https://sec-api.dev/companies/avxl

> AVXL’s SEC CIK is 0001314052 (1314052).

Insider transactions in the latest quarter: 0 (0 purchases, 0 sales). 

| Filed | Form | Filing |
| --- | --- | --- |
| 2026-11-06 | 4 | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001421/0001731122-26-001421-index.htm |
| 2026-11-06 | 4 | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001419/0001731122-26-001419-index.htm |
| 2026-11-06 | 4 | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001417/0001731122-26-001417-index.htm |
| 2026-11-06 | 4 | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001411/0001731122-26-001411-index.htm |

API: GET https://sec-api.dev/api/v1/filings?cik=1314052

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.
API: https://sec-api.dev/docs · ChatGPT app: https://chatgpt.com/plugins/plugin_asdk_app_6ae0ef2436ac8191941dae8a4d732669 · Free key: https://sec-api.dev/sign-up